Differences in adult and foetal human cytochrome P-450 forms recognized by monoclonal antibodies with specificity for the P450III family.

Por Barnes, T S, Burke, M D, Melvin, W T
Publicado em 1989

The influence of Tween 80 on the metabolism of biphenyl microsomal oxygenases.

Por Burke, M D, Bridges, J W
Publicado em 1972

The influence of storage conditions on microsomal drug-metabolizing activity.

Por Burke, M D, Bridges, J W
Publicado em 1972

Induction by phenobarbitone or 3-methylcholanthrene of the hepatic microsomal metabolism of harmine [proceedings]

Por Burke, M. D., Tweedie, D. J.
Publicado em 1979

Strain differences in the maintenance of cytochrome P-450 and mixed-function-oxidase activities in cultured rat hepatocytes. Effect of prostaglandins.

Por Grant, M H, Smith, S J, Burke, M D
Publicado em 1986

Glutathione localisation in benign and malignant human breast lesions.

Por Murray, G. I., Burke, M. D., Ewen, S. W.
Publicado em 1987

Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone 16 alpha-carbonitrile-inducible rat cytochromes P-450.

Por Barnes, T S, Shaw, P M, Burke, M D, Melvin, W T
Publicado em 1987

Fluorescence-microscopic measurement of intracellular cytochrome P-450 enzyme activity (ethoxyresorufin O-de-ethylation) in unfixed liver section.

Por Burke, M D, Murray, G I, Lees, G M
Publicado em 1983

Multiple forms of cytochrome P-450 related to forms induced marginally by phenobarbital. Differences in structure and in the metabolism of alkoxyresorufins.

Por Wolf, C R, Seilman, S, Oesch, F, Mayer, R T, Burke, M D
Publicado em 1986

Enhanced expression of cytochrome P450 in stomach cancer.

Por Murray, G. I., Taylor, M. C., Burke, M. D., Melvin, W. T.
Publicado em 1998

Comparative effects of indomethacin on hepatic enzymes and histology and on serum indices of liver and kidney function in the rat.

Por Falzon, M., Whiting, P. H., Ewen, S. W., Milton, A. S., Burke, M. D.
Publicado em 1985

Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.

Por Whiting, P. H., Barnard, N., Neilsch, A., Simpson, J. G., Burke, M. D.
Publicado em 1987

Daily rhythmic variatioins in hamster liver drug metabolism and associated parameters.

Por Burke, M D, Lake, B G, Tredger, J M, Chakraborty, J, Bridges, J W
Publicado em 1972

The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Por Murray, G I, Barnes, T S, Sewell, H F, Ewen, S W, Melvin, W T, Burke, M D
Publicado em 1988

Xenobiotic metabolising enzyme expression in colonic neoplasia.

Por McKay, J A, Murray, G I, Weaver, R J, Ewen, S W, Melvin, W T, Burke, M D
Publicado em 1993

Expression of cytochrome P450IA in breast cancer.

Por Murray, G. I., Foster, C. O., Barnes, T. S., Weaver, R. J., Ewen, S. W., Melvin, W. T., Burke, M. D.
Publicado em 1991

Cytochrome P450 expression in oesophageal cancer.

Por Murray, G I, Shaw, D, Weaver, R J, McKay, J A, Ewen, S W, Melvin, W T, Burke, M D
Publicado em 1994

Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.

Por Murray, G. I., Taylor, V. E., McKay, J. A., Weaver, R. J., Ewen, S. W., Melvin, W. T., Burke, M. D.
Publicado em 1995

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1

Por Potter, G A, Patterson, L H, Wanogho, E, Perry, P J, Butler, P C, Ijaz, T, Ruparelia, K C, Lamb, J H, Farmer, P B, Stanley, L A, Burke, M D
Publicado em 2002